Диссертация (1139571), страница 35
Текст из файла (страница 35)
Gorman, B.F. Gilmore // Expert Rev Anti Infect Ther. – 2013. – Vol. 11, №3.– P. 297–308.297. Pfeifer, Y. Resistance to cephalosporins and carbapenems in Gram-negativebacterial pathogens / Y. Pfeifer, A. Cullik, W. Witte // International Journal ofMedical Microbiology. – 2010. – Vol. 300, № 6. – P. 371-9.298. Pfeifer, Y.
Carbapenem-resistant Acinetobacter baumannii ST78 with OXA-72carbapenemase and ESBL gene blaCTX-M-115 / Y. Pfeifer, K.P. Hunfeld, S.Borgmann, D. Maneg, et al. // The Journal of Antimicrobial Chemotherapy . –2016. – Vol. 71. – P. 1426-8.299. Pilishvili, T. Pneumococcal disease prevention among adults: strategies for theuse of pneumococcal vaccines / T.
Pilishvili, N.M. Bennett // The AmericanJournal of Preventive Medicine. – 2015. – Vol. 49, № 4. – P. 383-390.300. Pilishvili, T. Sustained reductions in invasive pneumococcal disease in the era ofconjugate vaccine / T. Pilishvili, C. Lexau, M.M. Farley, et al. // The Journal ofInfectious Diseases. – 2010. – Vol. 201. – P. 32-41.301. Pirnay, J.P. Pseudomonas aeruginosa displays an epidemic population structure /J.P. Pirnay, D.
De Vos, C. Cochez, F. Bilocq, et al. // Applied and EnvironmentalMicrobiology. – 2002. – Vol. 4, № 12. – P. 898-911.302. Pocket book of hospital care for children: guidelines for the management ofcommon childhood ilinesses. 2nd ed. WHO. 2013.303. Podschun, R. Klebsiella spp. as Nosocomial Pathogens: Epidemiology,Taxonomy, Typing Methods, and Pathogenicity Factors / R. Podschun, U.Ullmann // a review. Clinical Microbiology. – 1998. – P. 589–603.304. Porat, N. The impact of pneumococcal conjugate vaccines on carriage of anddisease caused by Streptococcus pneumoniae serotypes 6C and 6D in southernIsrael / N.
Porat, R. Benisty, N. Givon-Lavi, R. Trefler,et al. // Vaccine. – 2016. –Vol. 34. – P. 2806-2812.223305. Potron, A. European dissemination of a single OXA-48 producing Klebsiellapneumoniae clone / A. Potron, J. Kalpoe, L. Poirel, P..Nordmann // The Journal ofClinical Microbiology. – 2011. – Vol. 17, № 12. – E. 24-6.306. Potron, A. Emerging broad-spectrum resistance in Pseudomonas aeruginosa andAcinetobacter baumannii: Mechanisms and epidemiology / A. Potron, L.
Poirel, P.Nordmann // International Journal of Antimicrobial Agents. – 2015. – Vol. 45, №6. – P.568-85.307. Praveen, S. Prevalence of streptococcal pharyngitis in pediatrics / S. Praveen, A.Prema // Journal of Pharma and Bio Sciences. – 2014. – Vol. 5, № 3. – P. 10171021.308. Principe, L.
Epidemic diffusion of OXA-23-producing Acinetobacter baumanniiisolates in Italy: results of the first cross-sectional countrywide survey // L.Principe, A. Piazza, T. Giani, S. Bracco, et al // Journal of Clinical Microbiology.– 2014. – Vol. 52. – P.3004-10.309. Protasova, I.N. Molecular characterization of Streptococcus pneumoniae,particularly serotype19A/ST320, that emerged in Krasnoyarsk, Russia / I.N.Protasova, T.W.
Wan, N.V. Bakhareva, W.C. Hung,et. al. // Journal ofMicrobiology, Immunology and Infection. – 2017. – Vol. 6, № 9. – P. 359-370.310. Pseudomonas aeruginosa MLST Database [database online]. Режим доступа:https://pubmlst.org/paeruginosa.311. Qadri, S. M. H. Polymicrobial septicemia due to Shigella flexneri andPseudomonas aeruginosa: first report / S. M. H. Qadri, S.
H. Khalil //Journal ofthe National Medical Association. – 1987. – Vol. 79, № 12. – P. 128 – 1292.312. Rachina, S. Prescribing of systemic antimicrobials for respiratory infections inchildren in primary care in Russia [Abstract P0370] / S. Rachina, R. Kozlov, L.Jarkova, Y. Belkova, et. al. // In: 24th ECCMID 2014, Barcelona, Spain.313. Reimmann, C. PchC thioesterase optimizes nonribosomal biosynthesis of thepeptide siderophore pyochelin in Pseudomonas aeruginosa / C. Reimmann, H. M.Patel, C.
T. Walsh, D. Haas //Journal of bacteriology. – 2004. – Vol.186, № 19. –P. 6367-6373.224314. Reinert, R. Pneumococcal disease caused by serotype 19A: review of theliteratyre and implications for future vaccine development / R. Reinert, M.R.Jacobs, S.L. Kaplan // Vaccine. – 2010. – Vol. 28. – P. 4249-59.315. Reinert, R.R. Advances in pneumococcal vaccines: the 13-valent pneumococcalconjugate vaccine received market authorization in Europe / R.R.Reinert, P.Paradiso, B.
Fritzel // Expert Review of Vaccines. – 2010. – Vol. 9. – P. 229–236.316. Reinert, R.R. The antimicrobial resistance profile of Streptococcus pneumoniae /R.R. Reinert // Clinical Microbiology and Infection. – 2009. – Vol. 15, № 3. – P.7-11.317. Reinert, R.R. Mechanisms of macrolide resistance among Streptococcuspneumoniae isolates from Russia / R.R.
Reinert, O.Y. Filimonova, A. Al-Lahham,S.A. Grudinina, et al. // Antimicrobial Agents and Chemotherapy. – 2008. – Vol.52. – P. 2260-2.318. Resti, M. Community-acquired bacteremic pneumococcal pneumonia inchildren: Diagnosis and Serotyping by Real-Time Polimerase Chene ReactionUsing Blood Samples / M. Resti, M. Moriondo, M. Cortimiglia, G. Indolfi, et al.// Clinical Infectious Diseases. – 2010. – Vol. 51, № 9.
– P. 1042-49.319. Retsema, J. Macrolides: structures and microbial targets / J.Retsema //International Journal of Antimicrobial Agents. – 2001. – P. 3-10.320. Richter, S.S. Changes in pneumococcal serotypes and antimicrobial resistanceafter introduction of the 13-valent conjugate vaccine in the United States / S.S.Richter, D.J. Diekema, K.P. Heilmann, C.L.
Dohrn, et al. // Antimicrobial Agentsand Chemotherapy. – 2014. – Vol. 58. – P. 6484-6489.321. Richter, S.S. Pneumococcal Serotypes before and after Introduction ofConjugate Vaccines, United States, 1999-2011 / S.S. Richter, K.P. Heilmann, C.L.Dohrn, F. Riahi, et al.
// Emerging Infectious Diseases. – 2013. – Vol. 19. – P.1074-83.322. Richter, S.S. The ongoing genetic adaptation of Streptococcus pneumoniae /S.S. Richter, D.M. Musher // The Journal of Clinical Microbiology. – 2017. – Vol.55. – P. 681-685.225323. Rojo-Bezares, B. Characterization of carbapenem resistance mechanisms andintegrons in Pseudomonas aeruginosa strains from blood samples in a Frenchhospital / B. Rojo-Bezares, L. Cavalié, D. Dubois, E.
Oswald, et al. // The Journalof Medical Microbiology. – 2016. – Vol. 65, № 4. – P. 311-9.324. Rodriguez-Bano, J. Biofilm formation in Acinetobacter baumannii: associatedfeatures and clinical implications / J. Rodriguez-Bano, S. Marti, S. Soto, F.Fernandez-Cuenca et al // European Journal of Clinical Microbiology & InfectiousDiseases. – 2008. – Vol. 14, № 3. – P. 276–278.325. Russo, T.A. The K1 capsular polysaccharide of Acinetobacter baumannii strain307-0294 is a major virulence factor / T.A. Russo, N.R. Luke, J.M.
Beanan, R.Olson et al // Infection and Immunity. – 2010. – Vol. 78, № 9. – P. 3993–4000.326. Salmen, P. Whirlpool-associated Pseudomonas aeruginosa urinary tractinfections / P. Salmen, D. M. Dwyer, H. Vorse, W. Kruse // The Journal of theAmerican Medical Association. – 1983. – Vol. 250, № 15. – P. 2025-2026.327. Sanchez, C. J. Biofilm formation by clinical isolates and the implications inchronic infections / C. J.
Sanchez, K. Mende, M. L. Beckius, K. S. Akers et al //BMC infectious diseases. – 2013. – Vol. 13, № 1. – P. 47.328. Schwaber, M.J. Predictors of carbapenem-resistant Klebsiella pneumoniaeacquisition among hospitalized adults and effect of acquisition on mortality / M.J.Schwaber, S.
Klarfeld-Lidji, S. Navon-Venezia, D. Schwartz, et al. //Antimicrobial Agents and Chemotherapy. – 2008. – Vol. 52, № 3. – P.1028-33.329. Seppala, H. Resistance to erythromycin in-group A streptococci / H. Seppala, A.Nissinen, H. Jarvinen, S. Huovinen et al. // The New England Journal ofMedicine. – 1992. – Vol. 326– P. 292-7.330. Seppala, H.
A novel erythromycin resistance methylase gene (ermTR) inStreptococcus pyogenes / H. Seppala, M. Skurnik, H. Soini, M.C. Roberts et al. //Antimicrobial Agents and Chemotherapy. – 1998. – Vol. 42. – P. 257-62.331. Setchanova, L. Dominance of multidrug-resistant Denmark14-32(ST230) cloneamong Streptococcus pneumoniae serotype 19A isolates causing pneumococcal226disease in Bulgaria from 1992 to 2013 / L. Setchanova, A. Alexandrova, D.Dacheva et al. // Microbial Drug Resistance. – 2015. – Vol.